Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  2/12/2016
Clinical Research Facility
mi
from
Limerick, PA
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 2/12/2016
Clinical Research Facility
mi
from
Limerick, PA
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  2/12/2016
Clinical Research Facility
mi
from
Philadelphia, PA
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 2/12/2016
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  2/12/2016
Clinical Research Facility
mi
from
Charleston, SC
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 2/12/2016
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  2/12/2016
Clinical Research Facility
mi
from
Columbia, SC
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 2/12/2016
Clinical Research Facility
mi
from
Columbia, SC
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  2/12/2016
Clinical Research Facility
mi
from
Germantown, TN
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 2/12/2016
Clinical Research Facility
mi
from
Germantown, TN
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  2/12/2016
Clinical Research Facility
mi
from
Nashville, TN
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 2/12/2016
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  2/12/2016
Clinical Research Facility
mi
from
Austin, TX
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 2/12/2016
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  2/12/2016
Clinical Research Facility
mi
from
Dallas, TX
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 2/12/2016
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  2/12/2016
Clinical Research Facility
mi
from
Galveston, TX
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 2/12/2016
Clinical Research Facility
mi
from
Galveston, TX
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  2/12/2016
Clinical Research Facility
mi
from
Houston, TX
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 2/12/2016
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  2/12/2016
Clinical Research Facility
mi
from
Logan, UT
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 2/12/2016
Clinical Research Facility
mi
from
Logan, UT
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  2/12/2016
Clinical Research Facility
mi
from
Ogden, UT
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 2/12/2016
Clinical Research Facility
mi
from
Ogden, UT
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  2/12/2016
Clinical Research Facility
mi
from
Burlington, VT
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 2/12/2016
Clinical Research Facility
mi
from
Burlington, VT
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  2/12/2016
Clinical Research Facility
mi
from
Chesapeake, VA
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 2/12/2016
Clinical Research Facility
mi
from
Chesapeake, VA
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  2/12/2016
Clinical Research Facility
mi
from
Christiansburg, VA
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 2/12/2016
Clinical Research Facility
mi
from
Christiansburg, VA
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  2/12/2016
Clinical Research Facility
mi
from
Fairfax, VA
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 2/12/2016
Clinical Research Facility
mi
from
Fairfax, VA
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  2/12/2016
Clinical Research Facility
mi
from
Richmond, VA
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 2/12/2016
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  2/12/2016
Clinical Research Facility
mi
from
Bellevue, WA
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 2/12/2016
Clinical Research Facility
mi
from
Bellevue, WA
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  2/12/2016
Clinical Research Facility
mi
from
Seattle, WA
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 2/12/2016
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  2/12/2016
Clinical Research Facility
mi
from
Spokane, WA
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 2/12/2016
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  2/12/2016
Clinical Research Facility
mi
from
Tacoma, WA
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 2/12/2016
Clinical Research Facility
mi
from
Tacoma, WA
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  2/12/2016
Clinical Research Facility
mi
from
Madison, WI
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 2/12/2016
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  2/12/2016
Clinical Research Facility
mi
from
Milwaukee, WI
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 2/12/2016
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated:  2/12/2016
mi
from
Adelaide,
An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling
Updated: 2/12/2016
mi
from
Adelaide,
Click here to add this to my saved trials
Safety and Health Intervention Project
Developing a Prescription Opioid Overdose Prevention Intervention in Addictions Treatment
Status: Enrolling
Updated:  2/13/2016
Community Programs, INC.
mi
from
Waterford, MI
Safety and Health Intervention Project
Developing a Prescription Opioid Overdose Prevention Intervention in Addictions Treatment
Status: Enrolling
Updated: 2/13/2016
Community Programs, INC.
mi
from
Waterford, MI
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
University of AZ College of Medicine
mi
from
Tucson, AZ
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
University of AZ College of Medicine
mi
from
Tucson, AZ
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
Center for Clinical Research
mi
from
Castro Valley, CA
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Center for Clinical Research
mi
from
Castro Valley, CA
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
ILD Consulting, Inc.
mi
from
Encinitas, CA
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
ILD Consulting, Inc.
mi
from
Encinitas, CA
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
Vascular Surgery Associates
mi
from
Los Angeles, CA
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Vascular Surgery Associates
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
UCSD Wound Treatment and Research Center
mi
from
San Diego, CA
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
UCSD Wound Treatment and Research Center
mi
from
San Diego, CA
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
University of Miami
mi
from
Miami, FL
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
Doctors Research Network
mi
from
South Miami, FL
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Doctors Research Network
mi
from
South Miami, FL
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
Robert J. Snyder
mi
from
Tamarac, FL
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Robert J. Snyder
mi
from
Tamarac, FL
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
Passavant Area Hospital
mi
from
Jacksonville, IL
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Passavant Area Hospital
mi
from
Jacksonville, IL
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
Rosalind Franklin University
mi
from
North Chicago, IL
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Rosalind Franklin University
mi
from
North Chicago, IL
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
Southern Illinois University
mi
from
Springfield, IL
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Southern Illinois University
mi
from
Springfield, IL
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
Johns Hopkins Wound Center
mi
from
Baltimore, MD
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Johns Hopkins Wound Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
Boston Med Ctr
mi
from
Boston, MA
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
New England Sinai Hospital
mi
from
Stoughton, MA
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
New England Sinai Hospital
mi
from
Stoughton, MA
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
Advanced Foot and Ankle Center
mi
from
Las Vegas, NV
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Advanced Foot and Ankle Center
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
Vincent Giacalone
mi
from
Emerson, NJ
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Vincent Giacalone
mi
from
Emerson, NJ
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
St. Luke's Roosevelt Hospital Center
mi
from
New York, NJ
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
St. Luke's Roosevelt Hospital Center
mi
from
New York, NJ
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
Overlook Hospital Wound Healing Program
mi
from
Summit, NJ
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Overlook Hospital Wound Healing Program
mi
from
Summit, NJ
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
Univ of North Carolina
mi
from
Chapel Hill, NC
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
Harrisburg Foot and Ankle Center
mi
from
Harrisburg, PA
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Harrisburg Foot and Ankle Center
mi
from
Harrisburg, PA
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
Center for Advanced Wound Care
mi
from
Reading, PA
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Center for Advanced Wound Care
mi
from
Reading, PA
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
Arlington Research Center
mi
from
Arlington, TX
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Arlington Research Center
mi
from
Arlington, TX
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
Wound Care Consultants
mi
from
Dallas, TX
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Wound Care Consultants
mi
from
Dallas, TX
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
Southwest Regional Wound Care Center
mi
from
Lubbock, TX
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Southwest Regional Wound Care Center
mi
from
Lubbock, TX
Click here to add this to my saved trials